Pubfacts - Scientific Publication Data
  • Categories
  • |
  • Journals
  • |
  • Authors
  • Login
  • Categories
  • Journals

Search Our Scientific Publications & Authors

Publications
  • Publications
  • Authors
find publications by category +
Translate page:

Prolonged Implantation of Sinus Devices and Implications for Chronic Rhinosinusitis: A Case Report and Review of the Literature.

Authors:
Saangyoung E Lee Drew Cutshaw Adam J Kimple Mark W Gelpi William C Brown Brian D Thorp Adam M Zanation Charles S Ebert

Surg Case Rep (Tallinn) 2020 Apr 28;3(4). Epub 2020 Apr 28.

Department of Otolaryngology/Head and Neck Surgery, University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, NC, United States.

Background: Implantation of sinus stents and spacers can be used as adjuvant management to maintain patency of sinuses after endoscopic sinus surgery for chronic rhinosinusitis. These implants are typically removed several weeks after surgery. We present two cases of different patients who were initially treated by different physicians and were found to have retained sinus spacers in their paranasal sinuses 6-10 years after implantation.

Case Presentation: Case 1: a 40-year old male with chronic rhinosinusitis and history of balloon sinuplasty six years prior presented with worsening symptoms of chronic rhinosinusitis refractory to medical management. He underwent revision functional endoscopic sinus surgery and was found to have retained sinus implants in the left and right frontal sinus recesses. Case 2: a 48-year-old female with long-standing chronic rhinosinusitis refractory to medical management presented after two prior sinus surgeries most recently 10 years ago. She underwent revision functional endoscopic surgery and was found to have a retained sinus implant from prior surgery in the right frontal recess outflow tract embedded within scar tissue and reactive hyperostosis. Foreign bodies from both patients were removed without complication and patients were healing appropriately in the post-operative period.

Conclusions: While sinus stents and spacers can help with post-operative scarring, leaving then unmonitored and in place will eventually result in them becoming a nidus for scarring and infection. It is critical that patients are aware of any foreign bodies we place, if they need scheduled removal or routine observation, and what symptoms may indicate that they are causing a problem.

Download full-text PDF

Source
http://dx.doi.org/10.31487/j.scr.2020.04.10DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7771652PMC
April 2020

Publication Analysis

Top Keywords

chronic rhinosinusitis
20
retained sinus
12
sinus
10
sinus surgery
8
endoscopic sinus
8
stents spacers
8
rhinosinusitis refractory
8
medical management
8
surgery retained
8
foreign bodies
8
functional endoscopic
8
underwent revision
8
sinus stents
8
refractory medical
8
revision functional
8
implantation sinus
8
surgery
5
rhinosinusitis
5
chronic
5
endoscopic surgery
4

Keyword Occurance

Similar Publications

COVID-19 vaccination of patients with allergies and type-2 inflammation with concurrent antibody therapy (biologicals) - A Position Paper of the German Society of Allergology and Clinical Immunology (DGAKI) and the German Society for Applied Allergology (AeDA).

Authors:
Oliver Pfaar Ludger Klimek Eckard Hamelmann Jörg Kleine-Tebbe Christian Taube Martin Wagenmann Thomas Werfel Randolf Brehler Natalija Novak Norbert Mülleneisen Sven Becker Margitta Worm

Allergol Select 2021 1;5:140-147. Epub 2021 Apr 1.

Allergology and Immunology, Department of Dermatotology, Venereology and Allergology, Charité Universitätsmedizin Berlin, Germany.

Background: After the beginning and during the worldwide pandemic caused by the severe acute respiratory syndrome coronavirus type 2 (SARS-CoV-2), patients with allergic and atopic diseases have felt and still feel insecure. Currently, four vaccines against SARS-CoV-2 have been approved by the Paul Ehrlich Institute in Germany, and vaccination campaigns have been started nationwide. In this respect, it is of utmost importance to give recommendations on possible immunological interactions and potential risks of immunomodulatory substances (monoclonal antibodies, biologicals) during concurrent vaccination with the approved vaccines. Read More

View Article and Full-Text PDF
April 2021
Similar Publications

A Phase II, Multicenter, Randomized, Placebo-Controlled Study of Benralizumab, a Humanized Anti-IL-5R Alpha Monoclonal Antibody, in Patients With Eosinophilic Chronic Rhinosinusitis.

Authors:
Tetsuji Takabayashi Daiya Asaka Yoshitaka Okamoto Tetsuo Himi Shinichi Haruna Naohiro Yoshida Kenji Kondo Mamoru Yoshikawa Yasunori Sakuma Kunihiko Shibata Motohiko Suzuki Masayoshi Kobayashi Ryo Kawata Kenzo Tsuzuki Mitsuhiro Okano Takaya Higaki Sachio Takeno Satoru Kodama Syuji Yonekura Hiromi Saito Akiyo Nozaki Nobuyoshi Otori Shigeharu Fujieda

Am J Rhinol Allergy 2021 Apr 11:19458924211009429. Epub 2021 Apr 11.

Department of Otorhinolaryngology-Head & Neck Surgery, University of Fukui, Fukui, Japan.

Background: Strong eosinophil infiltration in chronic rhinosinusitis with nasal polyp (CRSwNP) is highly associated with recalcitrance and higher nasal polyp recurrence rate after surgery. The prevalence of eosinophilic CRSwNP (ECRS) is increasing in Asian countries including Japan. Benralizumab is a humanized anti-IL-5R alpha monoclonal antibody that depletes eosinophils by antibody-dependent cell-mediated cytotoxicity. Read More

View Article and Full-Text PDF
April 2021
Similar Publications

Desmopressin effects on bleeding during functional endoscopic sinus surgery on patients with chronic rhinosinusitis.

Authors:
Fatemeh Hajimohamadi Jawad Hosseini Farrokh Heidari Sepideh Alvandi Shahin Bastaninezhad AmirHossein Ghabasiah Ardavan Tajdini

Am J Otolaryngol 2021 Mar 31;42(5):103024. Epub 2021 Mar 31.

Otorhinolaryngology Research Center, Tehran University of Medical Sciences, Tehran, Iran. Electronic address:

Objective: In this study we aimed to determine whether Desmopressin (DDAVP) can alter bleeding and improves surgeon visual field and decrease operation time or lessen use of anesthesiology medication in a clinical trial study.

Method: This study is a randomized clinical trial using the permuted block randomization method. 44 patients were enrolled in study and divided into two equal intervention-control groups. Read More

View Article and Full-Text PDF
March 2021
Similar Publications

Predictors of sinonasal disease onset, progression, and severity in pediatric cystic fibrosis patients.

Authors:
Michael S Weinstock Amber D Shaffer Amanda L Stapleton

Am J Otolaryngol 2021 Mar 31;42(5):103016. Epub 2021 Mar 31.

Department of Otolaryngology, Division of Pediatric Otolaryngology, University of Pittsburgh Medical Center Children's Hospital of Pittsburgh, Pittsburgh, PA, United States of America.

Purpose: Pediatric cystic fibrosis (CF) patients have a variable onset, severity, and progression of sinonasal disease. The objective of this study was to identify genotypic and phenotypic factors associated with CF that are predictive of sinonasal disease, recurrent nasal polyposis, and failure to respond to standard treatment.

Methods: A retrospective case series was conducted of 30 pediatric patients with CF chronic rhinosinusitis with and without polyps. Read More

View Article and Full-Text PDF
March 2021
Similar Publications

Postoperative Infection Rate and Associated Factors Following Endoscopic Sinus Surgery.

Authors:
Sharan J Shah Vivian S Hawn Nina Zhu Christina H Fang Qi Gao Nadeem A Akbar Waleed M Abuzeid

Ann Otol Rhinol Laryngol 2021 Apr 9:34894211007240. Epub 2021 Apr 9.

Division of Rhinology and Endoscopic Skull Base Surgery, Department of Otolaryngology-Head and Neck Surgery, University of Washington, Seattle WA, USA.

Objectives: There is a paucity of data on postoperative infections after endoscopic sinus surgery and associated risk factors. Our objective was to evaluate a cohort of patients undergoing endoscopic sinus surgery (ESS) for chronic rhinosinusitis to determine which perioperative factors may be associated with infection in the 30-day postoperative period.

Methods: A retrospective cohort study of adults who underwent ESS at a tertiary academic medical center from 2015 to 2018 was performed. Read More

View Article and Full-Text PDF
April 2021
Similar Publications
© 2021 PubFacts.
  • About PubFacts
  • Privacy Policy
  • Sitemap